Fur-imine-functionalized graphene oxide-immobilized copper oxide nanoparticles (Cu(II)-Fur-APTES/GO) are synthesized and found to be a cost-effective, efficient, and reusable heterogeneous nanocatalyst for the preparation of pharmaceutically important xanthene derivatives under greener solvent conditions. Cu(II)-Fur-APTES/GO exhibits excellent result in the synthesis of xanthenes with reduced reaction time (25−50 min) and higher yields (up to 95%) and has a simple procedure, ease of product separation, and no byproducts. Moreover, the nanocatalyst has a Cu loading of 13.5 at. % over functionalized GO which is far superior than the already known metal-based heterogeneous catalysts. The newly synthesized catalyst has been characterized by various physiochemical techniques such as X-ray photoelectron spectroscopy, X-ray diffraction, energy-dispersive X-ray, Raman spectroscopy for structural characterization, field emission scanning electron microscopy and high-resolution transmission electron microscopy for morphological characterization. The catalyst showed admirable recyclability up to five consecutive runs, and there was no appreciable loss in catalytic efficiency.
Herein, we report a facile approach to synthesize a new highly versatile heterogeneous catalyst by spontaneous aerial oxidation based on nickel oxide nanocomposites immobilized on surface-functionalized reduced graphene oxide sheets. NiO nanocomposite/reduced graphene oxide (rGO–NiO-NC) is a highly efficient, cost-effective, reusable, selective, and eco-friendly nano-catalyst that does not lose any activity even after five reaction cycles. Nickel loading on the rGO-NiO nanocomposite was found to be 3.3 at%, which contributes to the effective and efficient use of rGO–NiO-NCs as a nano-catalyst for the synthesis of imidazole derivatives. Consequently, a series of imidazole derivatives were synthesized, catalyzed by rGO–NiO-NCs, in 60 min with high yields (86% to 96%) under green conditions. Furthermore, the present synthetic methodology was used for the synthesis of highly aromatic imidazole derivatives (B1–B3) whose calf thymus-DNA binding affinities suggest their superior inhibition ability to displace ethidium bromide (EB), which was further confirmed by molecular docking studies. Additionally, the green chemistry matrix of the synthesis reaction was found to be very close to ideal values, such as carbon efficiency (82.32%), E-factor (0.51), atom economy (77.86%), process mass intensity (1.51), and reaction mass efficiency (66.14%).
Tuberculosis is one of the most dreadful diseases caused by Mycobacterium tuberculosis with more than 9 million individuals suffering from it in 2014. Traditional methods of detection are not efficient enough for its quick and reliable detection; therefore, it is imperative to develop methods of its detection in the early stages. Consequently, we report a highly sensitive and selective biosensor for detection of Mycobacterium tuberculosis. In this work, gold nanoparticles (AuNPs, dia. ∼6 nm, 1.81 wt% loading) are immobilized over reduced graphene oxide nanoribbons (RGONRs). An ssDNA/Au/RGONR electrode is prepared by immobilizing Au nanoparticles followed by covalent modification of Au nanoparticles with 5′SH-ssDNA. As per the best knowledge of the authors, the target DNA of Mycobacterium tuberculosis is detected using a ssDNA/Au/RGONR bioelectrode by cyclic voltammetry and chronoamperometric methods for the first time. With high detection efficiency (0.1 fM), the ssDNA/Au/RGONR bioelectrode exhibited better signal amplification and electrochemical response as compared to bare Au and RGONR electrodes. Additionally, the ssDNA/Au/RGONR bioelectrode displayed good linear response to different concentrations of target M. tuberculosis DNA. The ssDNA/Au/RGONR has shown excellent specificity (92%) to Mycobacterium tuberculosis target DNA as compared with non-complementary DNA. The Au/RGONR matrix has the potential to be used as an immobilization platform for single-stranded probe DNAs of different diseases other than tuberculosis reported here.